Amicus Therapeutics Inc FOLD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/18/24 EDT
11.58UNCH (UNCH)
Volume
33,947
Close
11.58UNCH (UNCH)
Volume
2,295,281
52 week range
9.70 - 14.57
Loading...
  • Open11.47
  • Day High11.84
  • Day Low11.38
  • Prev Close11.58
  • 52 Week High14.57
  • 52 Week High Date12/28/23
  • 52 Week Low9.70
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap3.421B
  • Shares Out295.38M
  • 10 Day Average Volume3.97M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-18.39

KEY STATS

  • Open11.47
  • Day High11.84
  • Day Low11.38
  • Prev Close11.58
  • 52 Week High14.57
  • 52 Week High Date12/28/23
  • 52 Week Low9.70
  • 52 Week Low Date11/10/23
  • Market Cap3.421B
  • Shares Out295.38M
  • 10 Day Average Volume3.97M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-18.39

RATIOS/PROFITABILITY

  • EPS (TTM)-0.51
  • P/E (TTM)-22.49
  • Fwd P/E (NTM)-98.14
  • EBITDA (TTM)-68.204M
  • ROE (TTM)-107.04%
  • Revenue (TTM)399.356M
  • Gross Margin (TTM)90.65%
  • Net Margin (TTM)-37.96%
  • Debt To Equity (MRQ)242.15%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amicus Therapeutics Inc

 

Profile

MORE
Amicus Therapeutics, Inc. is a biotechnology company, which is focused on discovering, developing, and delivering novel medicines for rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a novel treatment designed to improve uptake of active enzyme into key disease relevant tissues for adults living with late-onset Pompe disease. As an orally...
Michael Raab
Independent Chairman of the Board
Bradley Campbell
President & Chief Operating Officer
Simon Harford
Chief Financial Officer
Samantha Prout CPA
Chief Accounting Officer, Controller
Address
3675 Market Street
Philadelphia, PA
19104
United States

Top Peers

SYMBOLLASTCHG%CHG
BEAM
Beam Therapeutics Inc
34.06UNCHUNCH
RARE
Ultragenyx Pharmaceutical Inc
46.59UNCHUNCH
AXSM
Axsome Therapeutics Inc
72.54UNCHUNCH
DNLI
Denali Therapeutics Inc
20.09UNCHUNCH
INSM
Insmed Inc
26.14UNCHUNCH